FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3029713306> ?p ?o ?g. }

• W3029713306 endingPage "842" @default.
• W3029713306 startingPage "832" @default.
• W3029713306 abstract "Abstract Triple-negative breast cancer (TNBC) is a severe and heterogeneous disease that lacks an approved targeted therapy and has a poor clinical outcome to chemotherapy. Although the RAS-ERK signaling axis is rarely mutated in TNBC, ~50% of TNBCs show an increased copy number and overexpression of epidermal growth factor receptor (EGFR). However, EGFR-targeted therapies have offered no improvement in patient survival, underscoring the need to explore downstream targets, including RAS. We found that both β-catenin and RAS, as well as epidermal growth factor receptor (EGFR), are overexpressed and correlated with one another in tumor tissues of TNBC patients. KYA1797K, an Axin-binding small molecule reducing β-catenin and RAS expression via degradation and suppressing EGFR expression via transcriptional repression, inhibited the proliferation and the metastatic capability of stable cell lines as well as patient-derived cells (PDCs) established from TNBC patient tissues. KYA1797K also suppressed the stemness of 3D-cultured PDCs and xenografted tumors established by using residual tumors from TNBC patients and those established by the TNBC cell line. Targeting both the Wnt/β-catenin and RAS-ERK pathways via small molecules simultaneously reducing the levels of β-catenin, RAS, and EGFR could be a potential therapeutic approach for TNBC." @default.
• W3029713306 created "2020-06-05" @default.
• W3029713306 creator A5000975757 @default.
• W3029713306 creator A5020332540 @default.
• W3029713306 creator A5030577122 @default.
• W3029713306 creator A5033033849 @default.
• W3029713306 creator A5036350381 @default.
• W3029713306 creator A5052631858 @default.
• W3029713306 creator A5060939605 @default.
• W3029713306 creator A5064637828 @default.
• W3029713306 creator A5067941687 @default.
• W3029713306 date "2020-05-01" @default.
• W3029713306 modified "2023-10-15" @default.
• W3029713306 title "Destabilization of β-catenin and RAS by targeting the Wnt/β-catenin pathway as a potential treatment for triple-negative breast cancer" @default.
• W3029713306 cites W1812227581 @default.
• W3029713306 cites W1839791863 @default.
• W3029713306 cites W1861588860 @default.
• W3029713306 cites W1969346276 @default.
• W3029713306 cites W1989663680 @default.
• W3029713306 cites W1995224853 @default.
• W3029713306 cites W1998734250 @default.
• W3029713306 cites W1998914462 @default.
• W3029713306 cites W2006122819 @default.
• W3029713306 cites W2008870230 @default.
• W3029713306 cites W2011366619 @default.
• W3029713306 cites W2046350183 @default.
• W3029713306 cites W2070480410 @default.
• W3029713306 cites W2076446882 @default.
• W3029713306 cites W2085691361 @default.
• W3029713306 cites W2109462843 @default.
• W3029713306 cites W2118474093 @default.
• W3029713306 cites W2118605519 @default.
• W3029713306 cites W2124715710 @default.
• W3029713306 cites W2135736714 @default.
• W3029713306 cites W2139151018 @default.
• W3029713306 cites W2149441684 @default.
• W3029713306 cites W2158627893 @default.
• W3029713306 cites W2159640574 @default.
• W3029713306 cites W2168086498 @default.
• W3029713306 cites W2322937685 @default.
• W3029713306 cites W2421886702 @default.
• W3029713306 cites W2593682492 @default.
• W3029713306 cites W2742005115 @default.
• W3029713306 cites W2911422134 @default.
• W3029713306 cites W2925809780 @default.
• W3029713306 doi "https://doi.org/10.1038/s12276-020-0440-y" @default.
• W3029713306 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7272395" @default.
• W3029713306 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32457491" @default.
• W3029713306 hasPublicationYear "2020" @default.
• W3029713306 type Work @default.
• W3029713306 sameAs 3029713306 @default.
• W3029713306 citedByCount "20" @default.
• W3029713306 countsByYear W30297133062020 @default.
• W3029713306 countsByYear W30297133062021 @default.
• W3029713306 countsByYear W30297133062022 @default.
• W3029713306 countsByYear W30297133062023 @default.
• W3029713306 crossrefType "journal-article" @default.
• W3029713306 hasAuthorship W3029713306A5000975757 @default.
• W3029713306 hasAuthorship W3029713306A5020332540 @default.
• W3029713306 hasAuthorship W3029713306A5030577122 @default.
• W3029713306 hasAuthorship W3029713306A5033033849 @default.
• W3029713306 hasAuthorship W3029713306A5036350381 @default.
• W3029713306 hasAuthorship W3029713306A5052631858 @default.
• W3029713306 hasAuthorship W3029713306A5060939605 @default.
• W3029713306 hasAuthorship W3029713306A5064637828 @default.
• W3029713306 hasAuthorship W3029713306A5067941687 @default.
• W3029713306 hasBestOaLocation W30297133061 @default.
• W3029713306 hasConcept C121608353 @default.
• W3029713306 hasConcept C126322002 @default.
• W3029713306 hasConcept C137620995 @default.
• W3029713306 hasConcept C143998085 @default.
• W3029713306 hasConcept C170493617 @default.
• W3029713306 hasConcept C2776362946 @default.
• W3029713306 hasConcept C2779438470 @default.
• W3029713306 hasConcept C2780110267 @default.
• W3029713306 hasConcept C2781230642 @default.
• W3029713306 hasConcept C30145163 @default.
• W3029713306 hasConcept C502942594 @default.
• W3029713306 hasConcept C530470458 @default.
• W3029713306 hasConcept C57074206 @default.
• W3029713306 hasConcept C62478195 @default.
• W3029713306 hasConcept C71924100 @default.
• W3029713306 hasConcept C86803240 @default.
• W3029713306 hasConcept C95444343 @default.
• W3029713306 hasConceptScore W3029713306C121608353 @default.
• W3029713306 hasConceptScore W3029713306C126322002 @default.
• W3029713306 hasConceptScore W3029713306C137620995 @default.
• W3029713306 hasConceptScore W3029713306C143998085 @default.
• W3029713306 hasConceptScore W3029713306C170493617 @default.
• W3029713306 hasConceptScore W3029713306C2776362946 @default.
• W3029713306 hasConceptScore W3029713306C2779438470 @default.
• W3029713306 hasConceptScore W3029713306C2780110267 @default.
• W3029713306 hasConceptScore W3029713306C2781230642 @default.
• W3029713306 hasConceptScore W3029713306C30145163 @default.
• W3029713306 hasConceptScore W3029713306C502942594 @default.
• W3029713306 hasConceptScore W3029713306C530470458 @default.
• W3029713306 hasConceptScore W3029713306C57074206 @default.
• W3029713306 hasConceptScore W3029713306C62478195 @default.

• next